Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Xuanzhu Pharma Co Ltd patents


Recent patent applications related to Xuanzhu Pharma Co Ltd. Xuanzhu Pharma Co Ltd is listed as an Agent/Assignee. Note: Xuanzhu Pharma Co Ltd may have other listings under different names/spellings. We're not affiliated with Xuanzhu Pharma Co Ltd, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "X" | Xuanzhu Pharma Co Ltd-related inventors


Kinase inhibitor and use thereof

The invention relates to a CDK4/6 kinase inhibitor, or a pharmaceutically acceptable salt, ester, or solvate thereof, or their isomers; a pharmaceutical formulation, pharmaceutical composition and kit comprising said CDK4/6 kinase inhibitor, or a pharmaceutically acceptable salt, ester, or solvate thereof, or their isomers, and use of said CDK4/6 kinase... Xuanzhu Pharma Co Ltd

Quinazoline derivatives substituted by aniline, preparation method and use thereof

The invention relates to quinazoline derivatives substituted by aniline which are represented by the below formula (I), pharmaceutical acceptable salts and stereoisomer thereof, wherein these groups of R1, R2, R3, R4, R5, R6, L and n have the meanings given in the specification. The invention also relates to preparation methods,... Xuanzhu Pharma Co Ltd

Quinazoline derivatives substituted by aniline, preparation method and use thereof

The invention relates to quinazoline derivatives substituted by aniline which are represented by the below formula (I), pharmaceutical acceptable salts and stereoisomer thereof, wherein these groups of R1, R2, R3, R4, R5, R6, L and n have the meanings given in the specification. The invention also relates to preparation methods,... Xuanzhu Pharma Co Ltd

Polycyclic inhibitor of anaplastic lymphoma kinase

Disclosed is a polycyclic inhibitor of anaplastic lymphoma kinase as represented by Formula (I), or a pharmaceutically acceptable salt or stereoisomer thereof. Also disclosed is a method for preparing the compound, a pharmaceutical preparation and a pharmaceutical composition comprising the compound, and use of the compound, the pharmaceutically acceptable salt... Xuanzhu Pharma Co Ltd

Quinazoline derivative as tyrosine-kinase inhibitor, preparation method therefor and application thereof

The invention relates to a quinazoline derivative represented by the general formula (I), a pharmaceutical acceptable salt and a stereoisomer thereof as tyrosine kinase inhibitor, wherein R1, R2, R3, R3′, R4, R5, R6, X, L, T, Z and q are as defined in the specification. The invention also relates to... Xuanzhu Pharma Co Ltd

Tyrosine kinase inhibitor and uses thereof

Disclosed is a compound of Formula (I) or a pharmaceutically acceptable salt, ester, or solvate thereof, or their stereoisomers, which can be used as tyrosine kinase inhibitor. Also disclosed is a method for preparing the compound, a pharmaceutical composition and a kit comprising the compound, and uses of the compound.... Xuanzhu Pharma Co Ltd

C-glycoside derivative

wherein R1, R2, R3, R4, R5a, R5b, R5c and X are defined as in the description.... Xuanzhu Pharma Co Ltd








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Xuanzhu Pharma Co Ltd in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Xuanzhu Pharma Co Ltd with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###